Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation
Open Access
- 3 December 2024
- journal article
- research article
- Published by Elsevier in Annals of Hepatology
- Vol. 30 (1) , 101764
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
This publication has 24 references indexed in Scilit:
- Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearanceJournal of Gastroenterology, 2023
- Clinical usefulness of a novel high-sensitivity hepatitis B core-related antigen assay to determine the initiation of treatment for HBV reactivationJournal of Gastroenterology, 2022
- Outcome of nucleos(t)ide analog intervention in patients with preventive or on‐demand therapy for hepatitis B virus reactivationJournal of Medical Virology, 2020
- Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidanceHepatology, 2018
- Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibodyJournal of Gastroenterology, 2016
- Nationwide prospective and retrospective surveys for hepatitis B virus reactivation during immunosuppressive therapiesJournal of Gastroenterology, 2016
- Reactivation of hepatitis B # †Hepatology, 2009
- Correlation between serum hepatitis B virus core‐related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patientsJournal of Medical Virology, 2008
- HB Vaccination in the Prevention of Viral Reactivation in Allogeneic Hematopoietic Stem Cell Transplantation Recipients with Previous HBV InfectionTransplantation and Cellular Therapy, 2008
- Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapyGastroenterology, 1991